N, A., Y, S., W, T., N, O., P, P., M, P., . . . P, A. (2024). Efficacy of Bortezomib for Treating Anti-Interferon-Gamma Autoantibody-Associated Adult-Onset Immunodeficiency Syndrome. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 78(4), 1033. https://doi.org/10.1093/cid/ciad676
Chicago Style (17th ed.) CitationN, Angkasekwinai, Suputtamongkol Y, Tantibhedhyangkul W, Onlamoon N, Phoompoung P, Pithukpakorn M, Karuphong E, Pusuwan P, and Angkasekwinai P. "Efficacy of Bortezomib for Treating Anti-Interferon-Gamma Autoantibody-Associated Adult-Onset Immunodeficiency Syndrome." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 78, no. 4 (2024): 1033. https://doi.org/10.1093/cid/ciad676.
MLA (9th ed.) CitationN, Angkasekwinai, et al. "Efficacy of Bortezomib for Treating Anti-Interferon-Gamma Autoantibody-Associated Adult-Onset Immunodeficiency Syndrome." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 78, no. 4, 2024, p. 1033, https://doi.org/10.1093/cid/ciad676.